<?xml version="1.0" encoding="utf-8" standalone="no"?>
<!DOCTYPE file
  SYSTEM 'wikixml.dtd'>
<file type="Article" date="2024-09-24T08:25:07Z" sourceCorpus="COVID-19" filename="67278807" title="Chinese_Academy_of_Medical_Sciences_COVID-19_vaccine" url="https://en.wikipedia.org/wiki/Chinese_Academy_of_Medical_Sciences_COVID-19_vaccine">
	<text>
		<segment id="id67278807">Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (), is a COVID-19 vaccine developed by .

Clinical trials
In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.

In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.

Authorizations
image frame|content=Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|HK=turquoise
|NZ=turquoise

|caption=






On 9 June 2021, The vaccine has been approved by the Chinese authorities.

References


External links












</segment>
	</text>
</file>
